News

Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...
Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...
Todo por Antonio, or ‘All for Antonio’ is a benefit festival organised by his family, a boy with congenital muscular ...
Capricor’s BLA for Deramiocel was granted Priority Review in March 2025 and was supported by data from the HOPE-2 trial, its open-label extension (OLE), and natural history comparisons from FDA-funded ...
TAS-205 showed no significant impact on motor function in patients with Duchenne muscular dystrophy (DMD), highlighting the ongoing search for effective treatments for the rare condition.
After a decade-long search for answers to her difficulties with walking and other physical activities, Joanne Dalessandro of ...
In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation ...
Del-zota is designed for patients with mutations amenable to exon 44 skipping, which is just 7% of the overall DMD patient ...
As treatment for spinal muscular atrophy (SMA) has drastically improved over the last decade, so too have survival rates and the number of people with SMA living well into adulthood. | A new education ...
Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...
From sarcopenia to ALS, researchers are exploring creatine’s broader clinical potential — but more trials are needed to confirm its value.